Seventy-six consecutive cases of IOGEL intraocular lens implants.

A single piece hydrogel IOGEL (poly-HEMA) intraocular lens was implanted in 76 eyes. Patients obtained a visual acuity of 20/40 or better in 86.9% of cases and a best case visual acuity of 20/40 or better in 98.5% of cases. Patients were followed an average of 12 months (four to 19 months). Two lenses were exchanged with poly(methyl methacrylate) lenses because of decentration-induced glare. Cystoid macular edema occurred in two cases, resulting in visual acuity worse than 20/40 in one case. Results of the study at one year mean follow-up indicate the safety and efficacy of the IOGEL lens as an intraocular implant.